Hangzhou TianMuShan Pharmaceutical Enterprise Subsidiary Renews Business License

MT NewswiresNov 1 05:32 ET

Hangzhou Tianmushan Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

SZSIOct 29 12:00 ET · Announcements

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's (SHSE:600671) 30% Price Boost Is Out Of Tune With Revenues

Simply Wall StOct 28 18:10 ET

Tianmushan Pharmaceutical Enterprise Gets Nod to Re-Register Baihe Gujin Oral Liquid

MT NewswiresSep 23 03:42 ET

ST Pharmaceutical (600671.SH) has received 17 pharmaceutical re-registration approval notices.

Special treat Vision Pharmaceutical (600671.SH) released an announcement, the company recently received approval and issuance from the Zhejiang Provincial Pharmaceutical Regulatory Agency...

Zhitong FinanceSep 12 06:02 ET

ST Muyao (600671.SH): The controlling subsidiary plans to lease property.

On September 9, Gelonhui announced that its holding subsidiary, Qingdao Simulation Medical Technology Co., Ltd., plans to lease the Yung Jia Life Science and Technology Industrial Park A# building located at 603 Jiushui East Road, Laoshan District, Qingdao City, from Yung Jia Run Industrial Co., Ltd. The premises will be used for production, research and development, and office purposes, with a leasing area of approximately 7,862.71 square meters, for a lease term of 3 years from September 7, 2024 to September 6, 2027; the rent is payable annually, with the first year's rent being 6.3138 million yuan, the second year's rent being 6.5146 million yuan, and the third year's rent being 6.7155 million yuan.

Gelonghui FinanceSep 9 07:41 ET